Treats acne vulgaris. ANDA 212464, held by Padagis Israel. Adapalene; Benzoyl Peroxide.
As of Nov 16, 2026, ANDA 212464 (Adapalene And Benzoyl Peroxide), held by Padagis Israel, was first approved by FDA on May 31, 2022, with 0 approved supplements and 0 published complete response letters.
Adapalene and Benzoyl Peroxide Topical Gel, 0.3%/2.5% is indicated for the topical treatment of acne vulgaris in adults and pediatric patients 12 years of age and older.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 31, 2022 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Adapalene And Benzoyl Peroxide0.3%;2.5% · gel;topical | Adapalene; Benzoyl Peroxide | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters